📄 medicine
Suxiao Jiuxin Pills Attenuate Myocardial Ischemia Injury through Multi-Component Synergy and Ligustilide-Mediated AKT/GSK3β/HIF-1α Pathway Activation
This study demonstrates that Suxiao Jiuxin Pills protect against myocardial ischemia injury by improving cardiac function and reducing infarction, a therapeutic effect largely driven by the compound ligustilide activating the AKT/GSK3β pathway to suppress HIF-1α overexpression and stabilize mitochondrial homeostasis.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.